Dropprint Genomics develops software for analyzing individual cell activity in genomic data, serving researchers in immunology and drug discovery. The company reduces the cost and computational complexity of single-cell sequencing and maintains a database of over 1 million immune cells to support target identification using machine learning models.
Founders & leadership· Y Combinator alumni (W20)
RG
Rachel GateinCo-founder · Chief Executive Officer2019–2020Rachel Gate holds a PhD in bioinformatics from UCSF and cofounded Dropprint Genomics, which was acquired by Immunai. She currently develops new business initiatives in biotech.
MS
Meena SubramaniaminFounder
JY
Jimmie YeinFounder
Investors · 1
In the news
Frequently asked questions
- What does Dropprint Genomics do?
- Dropprint Genomics develops software for analyzing individual cell activity in genomic data, serving researchers in immunology and drug discovery. The company reduces the cost and computational complexity of single-cell sequencing and maintains a database of over 1 million immune cells to support target identification using machine learning models.
- Who founded Dropprint Genomics?
- Dropprint Genomics was founded by Rachel Gate, Meena Subramaniam, Jimmie Ye.
- Who are Dropprint Genomics's investors?
- Dropprint Genomics's investors include Y Combinator.
- Who acquired Dropprint Genomics?
- Dropprint Genomics was acquired by Immunai.
- Where is Dropprint Genomics headquartered?
- Dropprint Genomics is headquartered in San Francisco, US.